arginine vasopressin has been researched along with Depression in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (9.76) | 18.7374 |
1990's | 6 (14.63) | 18.2507 |
2000's | 11 (26.83) | 29.6817 |
2010's | 18 (43.90) | 24.3611 |
2020's | 2 (4.88) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Dong, C; Guo, T; Li, S; Liu, X; Miao, Y; Ren, T; Ruan, H; Sun, M; Wang, B; Wang, J; Wu, Q; Xin, N; Xu, X; Yang, Y; Yuan, Y; Zhang, HG; Zheng, H; Zuo, Y | 1 |
Jungwirth, B; Kagerbauer, SM; Martin, J; Podtschaske, AH; Ulm, B | 1 |
Hardin-Pouzet, H; Mhaouty-Kodja, S; Naulé, L | 1 |
Balesar, R; Bao, AM; Farajnia, S; Huang, M; Lu, J; Swaab, DF; Wu, X; Zhu, Q | 1 |
Hernandez, A; Keyes, LM; López-Espíndola, D; Martinez, ME; Stohn, JP; Zafer, M | 1 |
Bangasser, DA; Dalla, C; Hodes, GE; Kokras, N | 1 |
Bales, NJ; Borrow, AP; Daniels, RM; Fleury, TK; Handa, RJ; Heck, AL; Miller, AM; Sheng, JA; Stover, SA | 1 |
Joca, L; Raber, J; Siegel, JA; Zuloaga, DG | 1 |
Carlini, VP; Fiol de Cuneo, M; Kumar, P; Poretti, MB; Rask-Andersen, M; Rubiales de Barioglio, S; Schiöth, HB | 1 |
Cai, L; Li, R; Zhou, JN | 1 |
Choi, J; Han, PL; Kim, H; Kim, JE; Kim, TK; Lee, EH; Lee, JE; Park, JY | 1 |
Nelson, BS; Schank, JR; Sequeira, MK | 1 |
Changlani, S; Gueorguieva, R; Gunduz-Bruce, H; Kenney, J; Leone, C; Peixoto, A; Stachenfeld, N | 1 |
Brownstein, MJ; Fabio, K; Ferris, CF; Garripa, C; Guillon, C; Heindel, ND; Koppel, GA; Lu, SF; Miller, M; Simon, NG | 1 |
de Winter, RF; Goekoop, JG; Spinhoven, P; Wiegant, VM; Wolterbeek, R; Zitman, FG | 1 |
Erhardt, A; Holsboer, F; Keck, ME; Mueller, MB; Ohl, F; Sillaber, I; Thoeringer, CK | 1 |
Bettecken, T; Bunck, M; Czibere, L; Deussing, JM; Frank, E; Gonik, M; Graf, C; Holsboer, F; Horvath, C; Kessler, MS; Landgraf, R; Muigg, P; Müller-Myhsok, B; Murgatroyd, C; Panhuysen, M; Pütz, B; Singewald, N; Spengler, D; Weber, P | 1 |
Almeida, OF; Bockmühl, Y; Fischer, D; Holsboer, F; Micale, V; Murgatroyd, C; Patchev, AV; Spengler, D; Wotjak, CT; Wu, Y | 1 |
Lovejoy, DA; Rotzinger, S; Tan, LA | 1 |
Bhatnagar, S; Valentino, RJ; Walker, HE; Wood, SK | 1 |
de Winter, R; Goekoop, J; Wiegant, V; Wolterbeek, R | 1 |
Clarke, G; Cryan, JF; Desbonnet, L; Dinan, TG; Garrett, L; Kiely, B | 1 |
Kou, J; Peng, D; Tao, C; Xu, F; Yin, D; Yu, B; Zhu, D | 1 |
Hai, GF; Lu, L; Pan, YJ; Wang, DX; Wang, G; Wang, H; Yang, J; Yin, ZK; Zhao, Y | 1 |
Landgraf, R | 1 |
Cheng, Y; Jiang, Q; Ma, CG; Ming, L; Zhou, LL | 1 |
Anisman, H; Merali, Z; Poulter, MO; Prakash, P | 1 |
Ando, K; Aoki, M; Asai, M; Ito, Y; Mizuta, K; Nishihori, T | 1 |
Gold, PW; Goodwin, FK; Post, RM; Robertson, GL | 1 |
Ballenger, JC; Gold, P; Goodwin, FK; Post, RM; Rubinow, DR; Smallberg, SA; Summers, R; Weingartner, H | 1 |
Clarke, IJ; Engler, D; Funder, JW; Liu, JP | 1 |
Chrousos, GP; Gold, PW; Licinio, J; Wong, ML | 1 |
De Wied, D; Goekoop, JG; Lanser, JB; Van Londen, L; Wiegant, VM; Zwinderman, AH | 1 |
Dinan, TG; Scott, LV | 1 |
Gold, PW; Michelson, D | 1 |
Hamanaka, K; Kitayama, I; Nakase, S; Nomura, J; Soya, H | 1 |
Hofman, MA; Hoogendijk, WJ; Kamphorst, W; Liu, RY; Swaab, DF; Unmehopa, UA; van Heerikhuize, J; Zhou, JN | 1 |
Ekman, R; Gobom, J; Mecocci, P; Nilsson, CL; Persson, R | 1 |
Donald, RA; Inder, WJ; Joyce, PR; Mulder, RT; Prickett, TC | 1 |
Orenstein, H; Raskind, M; Weitzman, RE | 1 |
Ballenger, JC; Gold, PW; Goodwin, FK; Post, RM; Weingartner, H | 1 |
5 review(s) available for arginine vasopressin and Depression
Article | Year |
---|---|
Sex differences in the hypothalamic-pituitary-adrenal axis: An obstacle to antidepressant drug development?
Topics: Animals; Antidepressive Agents; Arginine Vasopressin; Corticotropin-Releasing Hormone; Depression; Drug Development; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Sex Characteristics | 2019 |
Vasopressin antagonists as anxiolytics and antidepressants: recent developments.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Arginine Vasopressin; Depression; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Vasopressins | 2008 |
Behavioral effects of neuropeptides in rodent models of depression and anxiety.
Topics: Animals; Anxiety; Arginine Vasopressin; Behavior, Animal; Cholecystokinin; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Galanin; Humans; MSH Release-Inhibiting Hormone; Neuropeptide Y; Neuropeptides; Neuropsychological Tests; Oxytocin; Social Behavior; Urocortins | 2010 |
Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs.
Topics: Adrenocorticotropic Hormone; Antidepressive Agents; Arginine Vasopressin; Corticotropin-Releasing Hormone; Cushing Syndrome; Depression; Depressive Disorder; Fatigue; Fatigue Syndrome, Chronic; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Seasonal Affective Disorder | 1995 |
Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Depression; Humans; Hypothalamo-Hypophyseal System; Pituitary-Adrenal System; Signal Transduction | 1998 |
2 trial(s) available for arginine vasopressin and Depression
Article | Year |
---|---|
Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Analysis of Variance; Arginine Vasopressin; Depression; Female; Fluoxetine; Humans; Hydrocortisone; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Statistics, Nonparametric | 2001 |
Effects of 1-desamo-8-D-arginine vasopressin on behaviour and cognition in primary affective disorder.
Topics: Affective Symptoms; Arginine Vasopressin; Cognition; Deamino Arginine Vasopressin; Depression; Evaluation Studies as Topic; Humans; Male; Memory, Short-Term | 1979 |
34 other study(ies) available for arginine vasopressin and Depression
Article | Year |
---|---|
Depression compromises antiviral innate immunity via the AVP-AHI1-Tyk2 axis.
Topics: Adaptor Proteins, Vesicular Transport; Animals; Antiviral Agents; Arginine Vasopressin; Depression; Depressive Disorder, Major; Immunity, Innate; Interferons; Leukocytes, Mononuclear; Meptazinol; Mice | 2022 |
Influence of perioperative stress on central and peripheral oxytocin and arginine-vasopressin concentrations.
Topics: Aged; Aged, 80 and over; Anxiety; Arginine Vasopressin; Depression; Female; Humans; Male; Middle Aged; Oxytocin; Perioperative Period; Pilot Projects; Saliva; Self Report; Stress, Psychological; Time Factors | 2019 |
[Estrogens and social and emotional related behaviors: Role of estrogen receptor β].
Topics: Age Factors; Animals; Arginine Vasopressin; Behavior, Animal; Depression; Emotional Regulation; Estrogen Receptor beta; Female; Hypothalamus; Male; Mice; Mutation; Neurons; Oxytocin; Sex Factors; Social Behavior; Testosterone; Tryptophan Hydroxylase | 2021 |
Increased glutamic acid decarboxylase expression in the hypothalamic suprachiasmatic nucleus in depression.
Topics: Aged; Aged, 80 and over; Arginine Vasopressin; Depression; Female; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Humans; Male; RNA, Messenger; Sex Factors; Statistics, Nonparametric; Suprachiasmatic Nucleus | 2017 |
Increased aggression and lack of maternal behavior in Dio3-deficient mice are associated with abnormalities in oxytocin and vasopressin systems.
Topics: Aggression; Animals; Anxiety; Arginine Vasopressin; Behavior, Animal; Brain; Depression; Female; Hypothalamus; Iodide Peroxidase; Male; Maternal Behavior; Mice; Mice, Inbred C57BL; Oxytocin; Social Behavior | 2018 |
Chronic variable stress alters hypothalamic-pituitary-adrenal axis function in the female mouse.
Topics: Animals; Anxiety; Arginine Vasopressin; Chronic Disease; Corticotropin-Releasing Hormone; Depression; Female; Gene Expression Regulation; Glucocorticoids; Hypothalamo-Hypophyseal System; Mice; Mice, Inbred C57BL; Oxytocin; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Restraint, Physical; Stress, Psychological | 2019 |
Long-term effects of early adolescent methamphetamine exposure on depression-like behavior and the hypothalamic vasopressin system in mice.
Topics: Animals; Animals, Newborn; Arginine Vasopressin; Behavior, Animal; Cognition; Depression; Female; Humans; Hypothalamo-Hypophyseal System; Male; Methamphetamine; Mice, Inbred C57BL; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Sex Characteristics; Time; Vasopressins | 2014 |
Ghrelin effects expression of several genes associated with depression-like behavior.
Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Antidepressive Agents; Arginine Vasopressin; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Ghrelin; Interleukin-1beta; Mice; Olfactory Bulb; Receptors, LH; Receptors, Opioid; Serotonin Plasma Membrane Transport Proteins | 2015 |
Chronic all-trans retinoic acid administration induces CRF over-expression accompanied by AVP up-regulation and multiple CRF-controlling receptors disturbance in the hypothalamus of rats.
Topics: Animals; Arginine Vasopressin; Corticosterone; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Estrogen Receptor beta; Gene Expression; Hypothalamus; Male; Motor Activity; Neurons; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Receptors, Mineralocorticoid; RNA, Messenger; Tretinoin | 2015 |
G9a-Mediated Regulation of OXT and AVP Expression in the Basolateral Amygdala Mediates Stress-Induced Lasting Behavioral Depression and Its Reversal by Exercise.
Topics: Animals; Arginine Vasopressin; Basolateral Nuclear Complex; Behavior, Animal; Depression; Histone-Lysine N-Methyltransferase; Male; Mice, Inbred C57BL; Oxytocin; Physical Conditioning, Animal; Receptors, Oxytocin; Receptors, Vasopressin; RNA, Small Interfering; Stress, Psychological; Transcription, Genetic; Up-Regulation | 2016 |
Bidirectional relationship between alcohol intake and sensitivity to social defeat: association with Tacr1 and Avp expression.
Topics: Alcohol Drinking; Alcoholism; Animals; Arginine Vasopressin; Behavior, Animal; Brain; Depression; Epigenesis, Genetic; Genetic Predisposition to Disease; Interpersonal Relations; Male; Mice; Receptors, Neurokinin-1; Resilience, Psychological; RNA, Messenger; Social Behavior; Stress, Psychological | 2018 |
A translational approach for NMDA receptor profiling as a vulnerability biomarker for depression and schizophrenia.
Topics: Adult; Arginine Vasopressin; Biomarkers; Depression; Female; Humans; Male; Osmolar Concentration; Receptors, N-Methyl-D-Aspartate; Saline Solution, Hypertonic; Schizophrenia; Water-Electrolyte Balance | 2017 |
Reduced cooperativeness and reward-dependence in depression with above-normal plasma vasopressin concentration.
Topics: Adult; Arginine Vasopressin; Cooperative Behavior; Depression; Female; Humans; Male; Middle Aged; Reward | 2009 |
Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL/6 mice.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Arginine Vasopressin; Corticosterone; Corticotropin-Releasing Hormone; Depression; GABA Agonists; GABA Plasma Membrane Transport Proteins; GABA Uptake Inhibitors; Gene Expression Regulation; Hippocampus; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Inbred C57BL; Nipecotic Acids; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Receptors, Steroid; RNA, Messenger; Tiagabine | 2010 |
A hypomorphic vasopressin allele prevents anxiety-related behavior.
Topics: Alleles; Animals; Anxiety; Arginine Vasopressin; Behavior, Animal; Depression; Female; Gene Expression Profiling; Humans; Male; Mice; Motor Activity; Neuropsychological Tests; Oligonucleotide Array Sequence Analysis; Oxytocin; Paraventricular Hypothalamic Nucleus; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Supraoptic Nucleus | 2009 |
Dynamic DNA methylation programs persistent adverse effects of early-life stress.
Topics: Animals; Animals, Newborn; Arginine Vasopressin; Behavior, Animal; Corticosterone; Depression; DNA Methylation; Enhancer Elements, Genetic; Epigenesis, Genetic; Hypothalamo-Hypophyseal System; Methyl-CpG-Binding Protein 2; Mice; Neurons; Paraventricular Hypothalamic Nucleus; Phenotype; Phosphorylation; Stress, Physiological; Transcription, Genetic | 2009 |
Individual differences in reactivity to social stress predict susceptibility and resilience to a depressive phenotype: role of corticotropin-releasing factor.
Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Arginine Vasopressin; Behavior, Animal; Body Weight; Cluster Analysis; Corticotropin-Releasing Hormone; Depression; Dominance-Subordination; Hypothalamo-Hypophyseal System; In Situ Hybridization; Individuality; Male; Paraventricular Hypothalamic Nucleus; Pituitary Gland; Pituitary-Adrenal System; Proto-Oncogene Proteins c-fos; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Restraint, Physical; RNA, Messenger; Stress, Physiological; Stress, Psychological; Time Factors | 2010 |
Support for two increased vasopressinergic activities in depression at large and the differential effect of antidepressant treatment.
Topics: Adult; Antidepressive Agents; Arginine Vasopressin; Depression; Female; Humans; Hydrocortisone; Male; Middle Aged; Receptors, Vasopressin | 2011 |
Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression.
Topics: Animals; Antidepressive Agents; Arginine Vasopressin; Behavior, Animal; Bifidobacterium; Biogenic Monoamines; Brain; Citalopram; Concanavalin A; Corticosterone; Corticotropin-Releasing Hormone; Cytokines; Depression; Disease Models, Animal; Female; Lipopolysaccharides; Maternal Deprivation; Probiotics; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stress, Psychological; Tryptophan | 2010 |
Anti-depression effects of Danggui-Shaoyao-San, a fixed combination of Traditional Chinese Medicine, on depression model in mice and rats.
Topics: Animals; Antidepressive Agents; Arginine Vasopressin; Behavior, Animal; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Humans; Male; Mice; Phytotherapy; Pituitary Gland; Plants, Medicinal; Rats; Rats, Sprague-Dawley; RNA, Messenger; Swimming | 2011 |
Effect of arginine vasopressin on the behavioral activity in the behavior despair depression rat model.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Behavior, Animal; Depression; Helplessness, Learned; Hindlimb Suspension; Injections, Intravenous; Injections, Intraventricular; Male; Pituitary Gland; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Spinal Cord; Swimming | 2012 |
[Neurobiology and genetics of anxiety in an animal model].
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Arginine Vasopressin; Arousal; Corticotropin-Releasing Hormone; Depression; Dexamethasone; Disease Models, Animal; Hypothalamo-Hypophyseal System; Motor Activity; Paroxetine; Phenotype; Pituitary-Adrenal System; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Rats; Rats, Inbred Strains; Receptors, Vasopressin | 2003 |
Antidepressant-like effects of BCEF0083 in the chronic unpredictable stress models in mice.
Topics: Animals; Antidepressive Agents; Arginine Vasopressin; Body Weight; Chronic Disease; Depression; Disease Models, Animal; Escape Reaction; Fungi; Male; Mice; Reward | 2005 |
Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice.
Topics: Analysis of Variance; Animals; Anxiety; Arginine Vasopressin; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Frontal Lobe; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Random Allocation; Receptors, Corticotropin-Releasing Hormone; RNA, Messenger; Species Specificity; Stress, Psychological; Tissue Distribution | 2007 |
The relevance of an elevation in the plasma vasopressin levels to the pathogenesis of Meniere's attack.
Topics: Adult; Aged; Aged, 80 and over; Arginine Vasopressin; Depression; Female; Humans; Male; Meniere Disease; Middle Aged; Osmolar Concentration; Plasma; Quality of Life; Retrospective Studies; Statistics as Topic; Surveys and Questionnaires; Vertigo | 2007 |
Vasopressin function in depression and mania [proceedings].
Topics: Affective Disorders, Psychotic; Anxiety; Arginine Vasopressin; Bipolar Disorder; Cognition; Depression; Humans; Psychotic Disorders; Saline Solution, Hypertonic | 1981 |
Effects of vasopressin on human memory functions.
Topics: Adult; Arginine Vasopressin; Cognition; Deamino Arginine Vasopressin; Depression; Female; Humans; Learning; Male; Memory; Middle Aged | 1981 |
Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituit
Topics: Animals; Anorexia Nervosa; Arginine Vasopressin; Corticotropin-Releasing Hormone; Cushing Syndrome; Depression; Female; Hypothalamo-Hypophyseal System; Neuropeptide Y; Norepinephrine; Pituitary-Adrenal System; Sheep; Sodium Chloride | 1994 |
Neuropsychological performance and plasma cortisol, arginine vasopressin and oxytocin in patients with major depression.
Topics: Adult; Aged; Analysis of Variance; Arginine Vasopressin; Attention; Chi-Square Distribution; Cognition; Cohort Studies; Depression; Depressive Disorder; Female; Humans; Hydrocortisone; Male; Memory; Middle Aged; Neuropsychological Tests; Oxytocin; Severity of Illness Index; Verbal Learning; Wechsler Scales | 1998 |
Pathophysiologic and somatic investigations of hypothalamic-pituitary-adrenal axis activation in patients with depression.
Topics: Adrenocorticotropic Hormone; Arginine Vasopressin; Bone Density; Depression; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Multiple Sclerosis; Pituitary-Adrenal System | 1998 |
Increased expression of magnocellular arginine vasopressin mRNA in paraventricular nucleus of stress-induced depression-model rats.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Depression; Disease Models, Animal; Male; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; RNA, Messenger; Stress, Physiological | 1998 |
Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Arginine Vasopressin; Circadian Rhythm; Depression; Female; Gene Expression; Humans; In Situ Hybridization; Male; Middle Aged; RNA, Messenger; Severity of Illness Index; Suprachiasmatic Nucleus | 2000 |
Arginine vasopressin in the cytoplasm and nuclear fraction of lymphocytes from healthy donors and patients with depression or schizophrenia.
Topics: Adult; Aged; Arginine Vasopressin; Blood Donors; Cell Nucleus; Cytoplasm; Depression; Humans; Lymphocytes; Middle Aged; Schizophrenia | 2001 |
Vasopressin in depression.
Topics: Arginine Vasopressin; Depression; Electroconvulsive Therapy; Female; Follow-Up Studies; Humans; Middle Aged | 1979 |